Summary
No AI-generated medical label claims were provided for evaluation. The content supplied appears to be pricing/logistics information and does not contain assessable prescribing-information claims (indications, dosing, contraindications, warnings, interactions, adverse reactions, or population use).
Category Scores
Accurate Statements
Unsupported Statements
Lactulose price varies by formulation (solution vs. syrup), strength, bottle size, and whether it is brand-name or generic.
The provided FDA label excerpts do not contain pricing statements; therefore this claim cannot be supported by the supplied prescribing information.
Generic lactulose is typically cheaper than brand lactulose in most markets.
The provided FDA label excerpts do not contain market pricing comparisons.
Generic lactulose has the same active ingredient and comparable dosage form to brand versions.
The provided FDA label excerpts do not discuss generic vs. brand equivalence or comparative dosage forms.
Insurance or Medicare can change lactulose price, with cost often reduced to a copay or coinsurance compared with the cash price.
The provided FDA label excerpts do not contain insurance/Medicare pricing or copay/coinsurance information.
Without insurance, cash prices for lactulose can be significantly higher, especially for larger bottles.
The provided FDA label excerpts do not contain cash-price statements.
Common drivers of lactulose cost include bottle size, concentration/strength, formulation (labeled syrups vs. solutions), whether paying cash or using insurance, and pharmacy location and dispensing fees.
The provided FDA label excerpts do not contain information about determinants of lactulose cost.
Contradictions
Important Omissions
Any AI-generated dosing, contraindication, warning/precaution, interaction, adverse reaction, monitoring, administration instruction, or population-specific use claim about lactulose that could be verified against the provided FDA label text.
Importance:
High
Safety Assessment
Potential Patient Risk:
Low
The supplied content focuses on pricing and does not include actionable dosing or safety claims. However, label-alignment evaluation is not possible because no prescribing-information claims were provided.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Medium |
Recommendation
Not Applicable
Primary Issue
No substantive prescribing-information claims (vs. FDA label) were provided to evaluate; the content is pricing-related.
Suggested Improvement
Paste the exact AI-generated medical/safety/dosing claim(s) you want audited against the provided lactulose label text (verbatim), and include the full AI response that contains those claims.